We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA ORDERS NDA SUBMISSION FOR PANCREATIC EXTRACT PRODUCTS
FDA ORDERS NDA SUBMISSION FOR PANCREATIC EXTRACT PRODUCTS
April 30, 2004
The FDA has ordered all manufacturers of exocrine pancreatic insufficiency drug products (PIDs) to submit new drug applications (NDAs) to the agency and have them approved within the next four years if they expect to remain on the market.